Table 3.
Comparison of quality-of-life outcomes in oropharyngeal patients undergoing exoscope-assisted surgery and (C)RT. Results are reported as value (%) and mean value ± standard deviation, as appropriate.
| Variable | Treatment approach: number (%) | p-value | |
|---|---|---|---|
| TOEOS = 16 (37.2) | (CT)RT = 27 (62.8) | ||
| UW-QOL (specific domains) | 1078.1 ± 182.8 | 1051.9 ± 148.2 | 0.39 |
| UW-QOL (global domains) | 141.9 ± 70.6 | 138.8 ± 50.8 | 0.95 |
| MDADI pre-treatment | 91.3 ± 15.3 | 99.2 ± 3.7 | 0.028 |
| MDADI post-treatment | 79.7 ± 20.3 | 82.3 ± 7.6 | 0.54 |
| Delta MDADI (pre-post) | 11.6 ± 17.1 | 16.9 ± 7.8 | 0.067 |
(CT)RT, (chemo)radiotherapy; TOEOS, transoral exoscopic oropharyngeal surgery; UW-QOL, University of Washington quality of life questionnaire; MDADI, M.D. Anderson dysphagia inventory.